| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Mean Platelet Volume | 4 | 2019 | 203 | 1.97 | Why? |
| Platelet Count | 5 | 2019 | 1381 | 1.56 | Why? |
| Dexmedetomidine | 2 | 2018 | 130 | 1.23 | Why? |
| Lipopolysaccharides | 4 | 2019 | 848 | 0.81 | Why? |
| Uncoupling Protein 2 | 1 | 2019 | 10 | 0.80 | Why? |
| Sepsis | 8 | 2019 | 3517 | 0.74 | Why? |
| alpha7 Nicotinic Acetylcholine Receptor | 2 | 2018 | 92 | 0.73 | Why? |
| Ventricular Function, Right | 1 | 2020 | 388 | 0.66 | Why? |
| Midazolam | 1 | 2017 | 79 | 0.65 | Why? |
| Kidney Tubules | 1 | 2018 | 205 | 0.64 | Why? |
| Clinical Deterioration | 1 | 2020 | 473 | 0.62 | Why? |
| Body Fluids | 1 | 2020 | 451 | 0.61 | Why? |
| Laryngeal Neoplasms | 1 | 2017 | 202 | 0.57 | Why? |
| Acute Kidney Injury | 4 | 2018 | 5762 | 0.55 | Why? |
| Cytokines | 4 | 2021 | 15010 | 0.55 | Why? |
| Anniversaries and Special Events | 1 | 2015 | 127 | 0.54 | Why? |
| Ventricular Dysfunction, Right | 1 | 2020 | 639 | 0.51 | Why? |
| Shock, Septic | 2 | 2020 | 1313 | 0.48 | Why? |
| Neoplasm Grading | 3 | 2019 | 400 | 0.48 | Why? |
| Cardiomyopathies | 2 | 2019 | 997 | 0.47 | Why? |
| RNA, Long Noncoding | 1 | 2017 | 408 | 0.47 | Why? |
| Heart Ventricles | 1 | 2020 | 1139 | 0.46 | Why? |
| Brain Neoplasms | 1 | 2019 | 669 | 0.45 | Why? |
| Hypnotics and Sedatives | 1 | 2017 | 624 | 0.45 | Why? |
| Stomach Neoplasms | 1 | 2017 | 477 | 0.44 | Why? |
| Neoplasm Staging | 4 | 2019 | 1999 | 0.41 | Why? |
| Neoplasm Metastasis | 3 | 2019 | 682 | 0.41 | Why? |
| Carcinoma, Non-Small-Cell Lung | 1 | 2019 | 896 | 0.39 | Why? |
| Bronchoscopy | 1 | 2017 | 991 | 0.37 | Why? |
| Apoptosis | 2 | 2018 | 2335 | 0.37 | Why? |
| Kaplan-Meier Estimate | 5 | 2019 | 4260 | 0.37 | Why? |
| Survivors | 1 | 2020 | 2619 | 0.35 | Why? |
| Colorectal Neoplasms | 2 | 2019 | 1884 | 0.33 | Why? |
| Patient Isolation | 1 | 2020 | 3182 | 0.31 | Why? |
| Melanoma | 1 | 2017 | 1229 | 0.31 | Why? |
| Blood Platelets | 1 | 2017 | 1704 | 0.30 | Why? |
| Intensive Care Units | 5 | 2021 | 29594 | 0.28 | Why? |
| Epithelial Cells | 1 | 2017 | 3508 | 0.28 | Why? |
| RNA, Small Interfering | 2 | 2019 | 817 | 0.25 | Why? |
| Kidney | 1 | 2017 | 3648 | 0.24 | Why? |
| Critical Care | 2 | 2017 | 14081 | 0.24 | Why? |
| Biomarkers | 7 | 2021 | 23361 | 0.23 | Why? |
| Lung Neoplasms | 1 | 2019 | 3228 | 0.22 | Why? |
| Fatal Outcome | 2 | 2021 | 3438 | 0.21 | Why? |
| China | 9 | 2020 | 50654 | 0.21 | Why? |
| ROC Curve | 3 | 2017 | 6024 | 0.21 | Why? |
| Pneumonia, Ventilator-Associated | 2 | 2018 | 861 | 0.21 | Why? |
| Neurons | 2 | 2017 | 864 | 0.21 | Why? |
| Transcription Factor TFIIH | 1 | 2019 | 4 | 0.20 | Why? |
| Anti-Inflammatory Agents | 2 | 2018 | 6153 | 0.20 | Why? |
| Mitochondria, Heart | 1 | 2019 | 37 | 0.20 | Why? |
| Receptors, Purinergic P2 | 1 | 2018 | 14 | 0.19 | Why? |
| Isothiocyanates | 1 | 2018 | 29 | 0.19 | Why? |
| Thiourea | 1 | 2018 | 37 | 0.19 | Why? |
| Podosomes | 1 | 2018 | 3 | 0.19 | Why? |
| Cytoprotection | 1 | 2018 | 44 | 0.19 | Why? |
| Leukemia, Promyelocytic, Acute | 1 | 2019 | 60 | 0.19 | Why? |
| Echocardiography, Doppler | 1 | 2020 | 269 | 0.19 | Why? |
| Arsenic | 1 | 2019 | 85 | 0.19 | Why? |
| Benzylidene Compounds | 1 | 2018 | 26 | 0.18 | Why? |
| Leptin | 2 | 2017 | 141 | 0.18 | Why? |
| HLA-DR Antigens | 1 | 2021 | 563 | 0.18 | Why? |
| Societies, Medical | 1 | 2015 | 6907 | 0.18 | Why? |
| Lipopolysaccharide Receptors | 1 | 2021 | 357 | 0.18 | Why? |
| Energy Metabolism | 3 | 2017 | 451 | 0.18 | Why? |
| High Fructose Corn Syrup | 1 | 2017 | 5 | 0.18 | Why? |
| Mitochondrial Proteins | 1 | 2019 | 152 | 0.18 | Why? |
| Gene Knockdown Techniques | 1 | 2019 | 347 | 0.18 | Why? |
| Ghrelin | 1 | 2017 | 22 | 0.18 | Why? |
| Serotonin 5-HT2 Receptor Agonists | 1 | 2017 | 3 | 0.17 | Why? |
| Sucrose | 1 | 2017 | 22 | 0.17 | Why? |
| Microtubule-Associated Proteins | 1 | 2019 | 187 | 0.17 | Why? |
| TRPC Cation Channels | 1 | 2017 | 7 | 0.17 | Why? |
| X-Box Binding Protein 1 | 1 | 2016 | 18 | 0.17 | Why? |
| Thermogenesis | 1 | 2016 | 14 | 0.17 | Why? |
| MAP Kinase Kinase 4 | 1 | 2017 | 36 | 0.17 | Why? |
| Prognosis | 6 | 2018 | 32490 | 0.17 | Why? |
| Male | 23 | 2021 | 367725 | 0.17 | Why? |
| Insulin Resistance | 3 | 2017 | 669 | 0.17 | Why? |
| Apoptosis Regulatory Proteins | 1 | 2018 | 202 | 0.17 | Why? |
| Mice, Inbred C57BL | 5 | 2018 | 5542 | 0.16 | Why? |
| Adenosine Triphosphate | 1 | 2019 | 294 | 0.16 | Why? |
| Volatile Organic Compounds | 1 | 2019 | 187 | 0.16 | Why? |
| Protective Clothing | 1 | 2020 | 468 | 0.16 | Why? |
| Glycolysis | 1 | 2017 | 208 | 0.16 | Why? |
| Health Services Accessibility | 1 | 2020 | 10697 | 0.15 | Why? |
| Reactive Oxygen Species | 2 | 2019 | 1136 | 0.15 | Why? |
| Models, Animal | 1 | 2019 | 788 | 0.15 | Why? |
| Tumor Burden | 1 | 2017 | 369 | 0.15 | Why? |
| Calcitonin | 1 | 2017 | 201 | 0.15 | Why? |
| Mice | 10 | 2019 | 21357 | 0.14 | Why? |
| Ventilator-Induced Lung Injury | 1 | 2018 | 260 | 0.14 | Why? |
| Personal Protective Equipment | 1 | 2020 | 15978 | 0.14 | Why? |
| Fungi | 1 | 2018 | 471 | 0.14 | Why? |
| Myocardial Reperfusion Injury | 1 | 2016 | 129 | 0.14 | Why? |
| Intestinal Perforation | 1 | 2017 | 178 | 0.14 | Why? |
| Propofol | 1 | 2017 | 172 | 0.14 | Why? |
| Catheterization, Peripheral | 1 | 2018 | 249 | 0.14 | Why? |
| Proportional Hazards Models | 2 | 2017 | 6543 | 0.14 | Why? |
| Endoplasmic Reticulum Stress | 1 | 2016 | 253 | 0.14 | Why? |
| Chemical and Drug Induced Liver Injury | 1 | 2019 | 451 | 0.14 | Why? |
| Adiposity | 1 | 2017 | 329 | 0.14 | Why? |
| Middle Aged | 14 | 2021 | 270681 | 0.13 | Why? |
| Drugs, Chinese Herbal | 2 | 2019 | 2760 | 0.13 | Why? |
| Methyltransferases | 1 | 2019 | 720 | 0.13 | Why? |
| Protein Precursors | 1 | 2017 | 425 | 0.13 | Why? |
| Transcription Factors | 1 | 2019 | 784 | 0.13 | Why? |
| Ultrasonography, Interventional | 1 | 2018 | 560 | 0.13 | Why? |
| Respiratory Function Tests | 1 | 2020 | 1755 | 0.12 | Why? |
| Humans | 27 | 2021 | 930598 | 0.12 | Why? |
| Myocytes, Cardiac | 1 | 2019 | 804 | 0.12 | Why? |
| Interleukin-6 | 3 | 2021 | 7522 | 0.12 | Why? |
| Endoribonucleases | 1 | 2016 | 407 | 0.12 | Why? |
| Pyridines | 1 | 2018 | 680 | 0.12 | Why? |
| Aged | 12 | 2020 | 215776 | 0.12 | Why? |
| Glucose Tolerance Test | 3 | 2017 | 238 | 0.12 | Why? |
| Disease Models, Animal | 3 | 2018 | 10998 | 0.11 | Why? |
| Exosomes | 1 | 2018 | 567 | 0.11 | Why? |
| Interleukin-1beta | 1 | 2017 | 992 | 0.11 | Why? |
| Autophagy | 1 | 2019 | 960 | 0.11 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.11 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.11 | Why? |
| Lung | 1 | 2020 | 31049 | 0.11 | Why? |
| Heart Injuries | 1 | 2018 | 608 | 0.11 | Why? |
| Multicenter Studies as Topic | 1 | 2018 | 2437 | 0.11 | Why? |
| Female | 14 | 2020 | 380317 | 0.11 | Why? |
| Signal Transduction | 2 | 2018 | 7207 | 0.11 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.11 | Why? |
| Retrospective Studies | 6 | 2020 | 105322 | 0.11 | Why? |
| Follow-Up Studies | 2 | 2020 | 17020 | 0.10 | Why? |
| Community-Acquired Infections | 2 | 2019 | 2328 | 0.10 | Why? |
| Biomarkers, Tumor | 1 | 2019 | 1314 | 0.10 | Why? |
| NF-kappa B | 1 | 2017 | 1301 | 0.10 | Why? |
| Multiple Organ Failure | 1 | 2020 | 1724 | 0.10 | Why? |
| Pneumonia | 2 | 2019 | 5652 | 0.10 | Why? |
| Animals | 11 | 2019 | 78931 | 0.10 | Why? |
| History, 20th Century | 1 | 2015 | 1282 | 0.09 | Why? |
| Pro-Opiomelanocortin | 2 | 2017 | 6 | 0.09 | Why? |
| Immunomodulation | 1 | 2017 | 1472 | 0.09 | Why? |
| Oxidative Stress | 1 | 2019 | 2050 | 0.09 | Why? |
| History, 21st Century | 1 | 2015 | 1849 | 0.09 | Why? |
| Inflammation | 3 | 2020 | 13255 | 0.09 | Why? |
| Patch-Clamp Techniques | 2 | 2017 | 49 | 0.09 | Why? |
| Bacteria | 1 | 2018 | 1897 | 0.09 | Why? |
| Mice, Knockout | 3 | 2017 | 1815 | 0.08 | Why? |
| Heart | 1 | 2017 | 1791 | 0.08 | Why? |
| Odds Ratio | 1 | 2019 | 5861 | 0.08 | Why? |
| Inflammation Mediators | 1 | 2018 | 2654 | 0.08 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2017 | 2483 | 0.08 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2019 | 3607 | 0.08 | Why? |
| Blood Glucose | 2 | 2017 | 3642 | 0.08 | Why? |
| Pandemics | 4 | 2020 | 389249 | 0.07 | Why? |
| Cells, Cultured | 1 | 2017 | 5835 | 0.07 | Why? |
| Immunotherapy | 1 | 2019 | 2421 | 0.07 | Why? |
| Blotting, Western | 2 | 2018 | 863 | 0.07 | Why? |
| Survival Rate | 1 | 2019 | 9206 | 0.07 | Why? |
| MicroRNAs | 1 | 2016 | 1787 | 0.06 | Why? |
| Antineoplastic Agents | 1 | 2019 | 3550 | 0.06 | Why? |
| Consensus | 1 | 2017 | 6345 | 0.06 | Why? |
| Glucose | 2 | 2017 | 573 | 0.06 | Why? |
| Randomized Controlled Trials as Topic | 2 | 2018 | 10649 | 0.06 | Why? |
| Neutrophils | 1 | 2018 | 5476 | 0.06 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.06 | Why? |
| Body Weight | 2 | 2017 | 1074 | 0.05 | Why? |
| Prospective Studies | 3 | 2020 | 43301 | 0.05 | Why? |
| Tertiary Care Centers | 1 | 2018 | 8248 | 0.05 | Why? |
| Arsenates | 1 | 2019 | 5 | 0.05 | Why? |
| Adult | 6 | 2020 | 244371 | 0.05 | Why? |
| Solid Phase Microextraction | 1 | 2019 | 20 | 0.05 | Why? |
| Neoplasm Transplantation | 1 | 2019 | 55 | 0.05 | Why? |
| Incidence | 2 | 2018 | 25622 | 0.05 | Why? |
| Bungarotoxins | 1 | 2018 | 4 | 0.05 | Why? |
| Gas Chromatography-Mass Spectrometry | 1 | 2019 | 187 | 0.05 | Why? |
| Zonula Occludens-1 Protein | 1 | 2018 | 54 | 0.05 | Why? |
| Respiration, Artificial | 3 | 2019 | 22116 | 0.04 | Why? |
| Mice, Nude | 1 | 2019 | 340 | 0.04 | Why? |
| Hexokinase | 1 | 2017 | 10 | 0.04 | Why? |
| Sweetening Agents | 1 | 2017 | 14 | 0.04 | Why? |
| Appetite Depressants | 1 | 2017 | 1 | 0.04 | Why? |
| Receptor, Serotonin, 5-HT2C | 1 | 2017 | 3 | 0.04 | Why? |
| Arcuate Nucleus of Hypothalamus | 1 | 2016 | 5 | 0.04 | Why? |
| Deoxyglucose | 1 | 2017 | 14 | 0.04 | Why? |
| Membrane Potentials | 1 | 2017 | 56 | 0.04 | Why? |
| Microscopy, Fluorescence | 1 | 2018 | 335 | 0.04 | Why? |
| Receptors, Tumor Necrosis Factor | 1 | 2016 | 40 | 0.04 | Why? |
| Benzazepines | 1 | 2017 | 49 | 0.04 | Why? |
| Network Meta-Analysis | 1 | 2019 | 426 | 0.04 | Why? |
| Bacterial Load | 1 | 2017 | 179 | 0.04 | Why? |
| Hypothalamus | 1 | 2016 | 58 | 0.04 | Why? |
| Blood Vessels | 1 | 2018 | 228 | 0.04 | Why? |
| I-kappa B Kinase | 1 | 2016 | 98 | 0.04 | Why? |
| Obesity | 1 | 2017 | 7388 | 0.04 | Why? |
| Tamoxifen | 1 | 2017 | 83 | 0.04 | Why? |
| Capillary Permeability | 1 | 2018 | 277 | 0.04 | Why? |
| Critical Illness | 1 | 2020 | 17281 | 0.04 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.04 | Why? |
| Pragmatic Clinical Trials as Topic | 1 | 2017 | 350 | 0.04 | Why? |
| Cold Temperature | 1 | 2016 | 260 | 0.04 | Why? |
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2016 | 229 | 0.04 | Why? |
| Laparotomy | 1 | 2017 | 241 | 0.04 | Why? |
| Severity of Illness Index | 2 | 2020 | 48226 | 0.04 | Why? |
| Young Adult | 3 | 2020 | 93724 | 0.04 | Why? |
| Time Factors | 1 | 2018 | 31397 | 0.03 | Why? |
| APACHE | 1 | 2017 | 682 | 0.03 | Why? |
| Lactic Acid | 1 | 2017 | 393 | 0.03 | Why? |
| Hospital Mortality | 1 | 2018 | 22087 | 0.03 | Why? |
| Eating | 1 | 2017 | 395 | 0.03 | Why? |
| Necrosis | 1 | 2016 | 532 | 0.03 | Why? |
| Body Composition | 1 | 2017 | 414 | 0.03 | Why? |
| Pseudomonas aeruginosa | 1 | 2018 | 652 | 0.03 | Why? |
| Aged, 80 and over | 2 | 2020 | 88759 | 0.03 | Why? |
| Homeostasis | 1 | 2016 | 582 | 0.03 | Why? |
| Quality Indicators, Health Care | 1 | 2017 | 580 | 0.03 | Why? |
| Risk Factors | 2 | 2018 | 71621 | 0.03 | Why? |
| Adipose Tissue | 1 | 2017 | 612 | 0.03 | Why? |
| Mice, Transgenic | 1 | 2018 | 2739 | 0.03 | Why? |
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2016 | 581 | 0.03 | Why? |
| Imidazoles | 1 | 2016 | 631 | 0.03 | Why? |
| Surveys and Questionnaires | 1 | 2018 | 43792 | 0.03 | Why? |
| Cross-Sectional Studies | 1 | 2018 | 53120 | 0.03 | Why? |
| Drug Resistance, Multiple, Bacterial | 1 | 2018 | 1115 | 0.03 | Why? |
| Cell Line, Tumor | 1 | 2019 | 3608 | 0.03 | Why? |
| L-Lactate Dehydrogenase | 1 | 2018 | 1995 | 0.02 | Why? |
| Immunohistochemistry | 1 | 2016 | 2275 | 0.02 | Why? |
| Monocytes | 1 | 2021 | 2978 | 0.02 | Why? |
| Renal Replacement Therapy | 1 | 2017 | 1530 | 0.02 | Why? |
| Insulin | 1 | 2017 | 1316 | 0.02 | Why? |
| Double-Blind Method | 1 | 2019 | 5988 | 0.02 | Why? |
| Antifungal Agents | 1 | 2018 | 1828 | 0.02 | Why? |
| Indoles | 1 | 2016 | 1243 | 0.02 | Why? |
| Endothelial Cells | 1 | 2018 | 2048 | 0.02 | Why? |
| Leukocyte Count | 1 | 2017 | 3178 | 0.02 | Why? |
| Myocardium | 1 | 2017 | 2323 | 0.02 | Why? |
| Acute Disease | 1 | 2017 | 6029 | 0.02 | Why? |
| Diet | 1 | 2017 | 2052 | 0.02 | Why? |
| Survival Analysis | 1 | 2017 | 7592 | 0.02 | Why? |
| Longitudinal Studies | 1 | 2018 | 9893 | 0.02 | Why? |
| Length of Stay | 1 | 2019 | 11042 | 0.01 | Why? |
| Adolescent | 2 | 2019 | 86841 | 0.01 | Why? |
| Infant, Newborn | 1 | 2019 | 23105 | 0.01 | Why? |
| Age Factors | 1 | 2018 | 21039 | 0.01 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2016 | 11367 | 0.01 | Why? |
| Anti-Bacterial Agents | 1 | 2018 | 10083 | 0.01 | Why? |
| Cross Infection | 1 | 2018 | 8675 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2017 | 22971 | 0.01 | Why? |
| Treatment Outcome | 1 | 2018 | 51732 | 0.01 | Why? |
| Child | 1 | 2019 | 70012 | 0.01 | Why? |